Department of Zoology, Spatial Ecology and Epidemiology Group, University of Oxford, South Parks Road, Oxford, UK.
Malar J. 2012 Jul 28;11:246. doi: 10.1186/1475-2875-11-246.
The last decade has seen a dramatic increase in international and domestic funding for malaria control, coupled with important declines in malaria incidence and mortality in some regions of the world. As the ongoing climate of financial uncertainty places strains on investment in global health, there is an increasing need to audit the origin, recipients and geographical distribution of funding for malaria control relative to populations at risk of the disease.
A comprehensive review of malaria control funding from international donors, bilateral sources and national governments was undertaken to reconstruct total funding by country for each year 2006 to 2010. Regions at risk from Plasmodium falciparum and/or Plasmodium vivax transmission were identified using global risk maps for 2010 and funding was assessed relative to populations at risk. Those nations with unequal funding relative to a regional average were identified and potential explanations highlighted, such as differences in national policies, government inaction or donor neglect.
US$8.9 billion was disbursed for malaria control and elimination programmes over the study period. Africa had the largest levels of funding per capita-at-risk, with most nations supported primarily by international aid. Countries of the Americas, in contrast, were supported typically through national government funding. Disbursements and government funding in Asia were far lower with a large variation in funding patterns. Nations with relatively high and low levels of funding are discussed.
Global funding for malaria control is substantially less than required. Inequity in funding is pronounced in some regions particularly when considering the distinct goals of malaria control and malaria elimination. Efforts to sustain and increase international investment in malaria control should be informed by evidence-based assessment of funding equity.
过去十年,国际和国内疟疾控制资金大幅增加,同时世界一些地区的疟疾发病率和死亡率也显著下降。随着财政不确定性的持续,对全球卫生投资造成压力,越来越有必要审查疟疾控制资金的来源、接受者和地理分布情况,以了解其与疾病风险人群的关系。
对国际捐助者、双边来源和各国政府的疟疾控制资金进行了全面审查,以重建 2006 年至 2010 年各国每年的总资金情况。使用 2010 年全球疟疾风险图确定受恶性疟原虫和/或间日疟原虫传播风险的地区,并根据风险人群评估资金情况。确定了与区域平均水平相比资金分配不平等的国家,并突出了潜在的解释,例如国家政策差异、政府不作为或捐助者忽视。
在研究期间,为疟疾控制和消除规划拨付了 89 亿美元。非洲的人均风险资金最高,大多数国家主要由国际援助支持。相比之下,美洲国家通常通过国家政府供资得到支持。亚洲的拨款和政府资金要低得多,资金模式差异很大。讨论了资金相对较高和较低的国家。
全球疟疾控制资金远远低于所需水平。在一些地区,资金分配不平等问题非常突出,尤其是在考虑到疟疾控制和消除的不同目标时。为了维持和增加国际对疟疾控制的投资,应该根据资金公平性的循证评估来指导。